Evidence map›Paper›PMID 40330004›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2025

Diagnostic Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in HLA-B27-Associated Acute Anterior Uveitis.

Varan Varadisai, Thanapong Somkijrungroj, Wijak Kongwattananon

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Varan VaradisaiDepartment of Ophthalmology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.ORCID 0009-0002-2742-771X
Thanapong SomkijrungrojDepartment of Ophthalmology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Wijak KongwattananonDepartment of Ophthalmology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.ORCID 0000-0002-3459-7197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as inflammatory markers in patients with HLA-B27-associated acute anterior uveitis (AAU) compared to healthy controls. Methods: This retrospective case-control study included 42 patients diagnosed with HLA-B27-associated AAU and 42 age- and sex-matched healthy controls. Ocular findings, uveitis activity, and hematologic parameters were extracted from medical records. The NLR and PLR were calculated and compared between groups to assess their diagnostic value. Results: Both NLR and PLR were significantly elevated in the HLA-B27 AAU group (Mean ± SD: 3.46 ± 2.08 and 171.53 ± 88.44) compared to controls (1.59 ± 0.61 and 123.94 ± 48.67, respectively) (p < 0.001 and p = 0.003). White blood cell count (WBC), neutrophil count, and platelet count were also significantly higher in the AAU group. Receiver operating characteristic (ROC) curve analysis showed that NLR had an area under the curve (AUC) of 0.798, with 71.4% sensitivity and 88.1% specificity, while PLR had an AUC of 0.679, with 64.3% sensitivity and 71.4% specificity. Conclusion: Patients with HLA-B27-associated AAU exhibited significantly higher NLR and PLR compared to controls. These hematologic markers reflect systemic inflammation but are not disease specific. NLR and PLR may serve as an adjunctive indicator in patients presenting with clinical signs of active HLA-B27 AAU.

Indexed as

AAUacute anterior uveitisHLA-B27HLA-B27 AAUneutrophil-to-lymphocyte ratioNLRplatelet-to-lymphocyte ratioPLR

Identifiers

PMID40330004
PMCPMC12054543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.